Response to: Circulating Tumor Cells and Detection of Melanoma-Associated Antigen HMW-MAA in the Serum of Melanoma Patients
✍ Scribed by Reynolds, Sandra R; Ferrone, Soldano; Bystryn, Jean-Claude
- Book ID
- 110049233
- Publisher
- Nature Publishing Group
- Year
- 2006
- Tongue
- English
- Weight
- 35 KB
- Volume
- 126
- Category
- Article
- ISSN
- 0022-202X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Simple, noninvasive methods are needed to follow effectiveness of new treatments in patients with melanoma. In our study, we examined cytoplasmic melanoma‐associated antigen (CYT‐MAA) serum level in melanoma patients during immunotherapy. Sera of 117 patients were assayed for CYT‐MAA by
## Abstract The lack of efficacy of available therapies for the treatment of malignant melanoma has emphasized the need to develop novel therapeutic strategies to prevent melanoma growth. We have tested whether the anti‐HMW‐MAA mAb 225.28S is able to inhibit human melanoma tumor growth in SCID mice
## Abstract Using allogeneic antibody, we previously described a highmolecular‐weight glycoprotein in the urine of 68% of melanoma patients. This glycoprotein has been termed urinarytumor‐associated antigen (U‐TAA). A murine monoclonal antibody (MAb) specific for U‐TAA (AD1‐40F4) has been developed